Astrocytes are the major intracerebral source of macrophage inflammatory protein-3α/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro

GLIA

Volumn 41, Issue 3, 2003, Pages 290-300

  Ambrosini, Elena ^a   Columba Cabezas, Sandra ^a   Serafini, Barbara ^a   Muscella, Antonella ^a   Aloisi, Francesca ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Chemokines; Glial cells; Neuroinflammation; T helper cells

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; B LYMPHOCYTE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MEMORY CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN SECRETION; RECURRENT DISEASE; T LYMPHOCYTE;

ANIMALS; ASTROCYTES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES, CC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE INFLAMMATORY PROTEINS; MICE; MICE, INBRED STRAINS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TH1 CELLS; TH2 CELLS;

EID: 0037327907     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10193     Document Type: Article

References (47)

1. Aloisi F, Carè A, Borsellino G, Gallo P, Rosa S, Bassani A, Cabibbo A, Testa U, Levi G, Peschle C. 1992. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 149:2358-2366.
2. Aloisi F, Ria F, Penna G, Adorini L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671-4680.
3. 2 secretion by microglia during antigen presentation to Thl cells. J Immunol 162:1384-1391.
4. Aloisi F. 2001. Immune function of microglia. Glia 36:165-179.
5. Aloisi F, Serafini B, Columba-Cabezas S, Adorini L. 2001. Dendritic cells in the central nervous system. In: Lotze MT, Thomson AW, editors. Dendritic cells: biology and clinical applications, 2nd ed. New York: Academic Press. p 371-387.
6. Baggiolini M. 1998. Chemokines and leukocyte traffic. Nature 392:565-568.
7. + T-cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 96:6873-6878.
8. Barna BP, Pettay J, Barnett GH, Zhou P, Iwasaki K, Estes ML. 1994. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF. J Neuroimmunol 50:101-107.
9. Barnes DA, Huston M, Holmes R, Benveniste EN, Yong VW, Scholz P, Perez HD. 1996. Induction of RANTES expression by astrocytes and astrocytoma cell lines. J Neuroimmunol 71:207-214.
10. Chabaud M, Page G, Miossec P. 2001. Enhancing effect of IL-1, IL-17, and TNFα on macrophage inflammatory protein-3α production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 167:6015-6020.
11. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. 1999. Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal Langherans cells. J Exp Med 190:1755-1767.
12. Columba-Cabezas S, Serafini B, Ambrosini E, Sanchez M, Penna G, Adorini L, Aloisi F. 2002. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J Neuroimmunol 130:10-21.
13. Cross AH, Trotter JL, Lyons J. 2001. B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112:1-14.
14. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C. 2000. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surface and is the most potent chemokine known in attracting Langherans cell precursors. J Exp Med 192:705-717.
15. + T-cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166:7617-7624.
16. Fujiie S, Hieshima K, Izawa D, Nakayama T, Fijisawa R, Ohyanagi H, Yoshie O. 2001. Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha/CCL20 in mucosal epithelial cells through NF-kappaB. Int Immunol 13:1255-1263.
17. Glabinski A, Tani M, Strieter RM, Tuohy V, Ransohoff RM. 1997. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of experimental autoimmune encephalomyelitis. Am J Pathol 150:617-630.
18. Glabinski AR, Ransohoff RM. 1999. Chemokines and chemokine receptors in CNS pathology. J Neurovirol 5:3-12.
19. Godiska R, Chantry D, Dietsch GN, Gray PW. 1995. Chemokine expression in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 58:167-176.
20. Hayashi M, Luo Y, Laning J, Strieter RM, Dorf ME. 1995. Production and function of monocyte chemoattractant protein-1 and other betachemokines in murine glial cells. J Neuroimmunol 60:143-150.
21. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
22. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Takasuki K, Miura R, Yoshie O, Nomiyama H. 1997. Molecular cloning of a novel CC chemokine liver and activation regulated chemokine (LARC) expressed in liver: chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 272:5846-5853.
23. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Muller A, de Waal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A. 2000. Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-6632.
24. Hua LL, Lee SC. 2000. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 30:74-81.
25. Huang DR, Wang J, Kivisäkk P, Rollins BJ, Ransohoff RM. 2001. Absence of monocyte chemoattractant protein-1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193:713-726.
26. Karpus WJ, Lukacs NW, Mc Rae BL, Strieter RM, Kunkel SL, Miller SD. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155:5003-5010.
27. Karpus WJ, Ransohoff RM. 1998. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161:2667-2671.
28. Krzysiek R, Lefevre EA, Bernard J, Foussat A, Galanaud P, Louache F, Richard Y. 2000. Regulation of CCR6 chemokine receptor expres sion and responsiveness to macrophage inflammatory protein-3α/CCL20 in human B cells. Blood 96:2338-2345.
29. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. 1999. CC chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J Immunol 162:186-194.
30. Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, Nishimura A, Endo H, Kitasato H, Kawai S, Tagagishi K, Kondo H. 2001. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin Exp Immunol 125:155-161.
31. Matyszak MK, Perry H. 1996. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74:599-562.
32. Merrill JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10, PL mice. Proc Natl Acad Sci USA 89:574-578.
33. Miyagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K. 1997. Identification of cell types producing RANTES, MIP-1α and MIP-1β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 77:17-26.
34. Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, Izawa D, Fujiie S, Tezuka T, Yoshie O. 2001. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3α/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 13:95-103.
35. Olsson T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268.
36. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, Yong VW, Ransohoff RM, MacVicar BA. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21:7135-7142.
37. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VH. 1993. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7:592-600.
38. Sallusto F, Lanzavecchia A, Mackay CR. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574.
39. Serafini B, Columba-Cabezas S, Di Rosa F, Aloisi F. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157:1991-2002.
40. Simpson J, Newcombe J, Cuzner ML, Woodroofe MN. 1998. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238-249.
41. Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
42. Steinman L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511-514
43. Tanaka Y, Imai T, Baba M, Ishikawa I, Uehira M, Nomiyama H, Yoshie O. 1999. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 29:633-642.
44. Tohyama M, Shirakara Y, Yamasaki K, Sayama K, Hashimoto K. 2001. Differentiated keratinocytes are responsible for TNF-alpha regulated production of macrophage inflammatory protein-3 alpha/CCL20, a potent chemokine for Langerhans cells. J Dermatol Sci 27:130-139.
45. Varona R, Zaballos A, Gutierrèz J, Martin P, Roncal F, Albar JC, Ardavin C, Màrquez G. 1998. Molecular cloning, functional characterization and mRNA expression analysis of the murine chemokine receptor CCR6 and its specific ligand MIP-3α. FEBS Lett 440:188-194.
46. Wingerchuk DM, Lucchinetti CF, Noseworthy JH. 2001. Multiple sclerosis: current pathophysiological concepts. Lab Invest 81:263-281.
47. Zlotnik A, Yoshie O. 2000. Chemokines a new classification system and their role in immunity. Immunity 12:121-127.